Research graph
References from Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up. Local targets link to admitted publications; unresolved targets remain external evidence.
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum
10.1016/j.ejca.2013.06.048 · 2014 · External reference
Oxaliplatin added to fluorouracil-based preoperative chemotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomized, phase 3 trial
10.1016/s1470-2045(15)00159-x · 2015 · External reference
Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdt240 · 2013 · External reference
Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies
2002 · External reference
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the Phase III Trial ACCORD 12/0405-Prodige 2
10.1200/jco.2009.25.8376 · 2010 · External reference
Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies
10.1016/j.ijrobp.2004.01.051 · 2004 · External reference
Primary tumor response to preoperative Chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic Results of the STAR-01 Randomized Phase III trial
10.1200/jco.2010.34.4911 · 2011 · External reference
Infusional 5-fluorouracil and ZD1839 (gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II trial Int
10.1016/j.ijrobp.2008.01.046 · 2008 · External reference
Dislocation of small bowel volume within box pelvic treatment fields, using new “up down table” device
10.1016/s0360-3016(01)01644-3 · 2011 · External reference
Randomized trial comparing monthly low-dose leucovorin and flourouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study
10.1200/jco.1997.15.2.808 · 1997 · External reference
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlation
10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · 1994 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years
10.1200/jco.2011.40.1836 · 2012 · External reference
Long-term treatment of metastatic colorectal cancer with panitumumab
10.4137/cmo.s5055 · 2012 · External reference
Approval summary: cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first line treatment of patients with recurrent loco-regional or metastatic squamous cell head and neck cancer
10.1634/theoncologist.2012-0458 · 2013 · External reference
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)
10.1200/jco.2011.39.6036 · 2012 · External reference
Does the addition of cetuximab to radiochemotherapy improve outcome of patients with locally advanced rectal cancer? long-term results from phase II trials
10.1155/2015/273489 · 2015 · External reference
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer
10.1016/j.ijrobp.2007.07.2356 · 2008 · External reference
The prognostic significance of tumor epidermal growth factor re- ceptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma
2015 · External reference
Increased toxicity with gefitinib, capacitabine, and radiation therapy in pancreatic and rectal cancer: Phase I trial results
10.1200/jco.2005.04.1749 · 2006 · External reference
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line
10.1007/s00384-013-1754-1 · 2014 · External reference
Late side effects of short-course preoperative radiotherapy combined with total mesolectal excision for rectal cancer:increased bowel-disfuntion in irradiated patients-a Dutch colorectal cancer group study
10.1200/jco.2005.14.779 · 2005 · External reference
Impact of short-therm preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multi center randomized trial
10.1200/jco.2005.05.256 · 2005 · External reference
Impact of short-course preoperative radiotherapy for rectal cancer on patients quality of life: data from the medical research council CR/07/National Cancer Institute of Canada clinical trials group C016 randomized clinical trial
10.1200/jco.2009.26.5264 · 2010 · External reference
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome
10.1007/s00464-013-2842-6 · 2013 · External reference
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial
10.1097/dcr.0b013e3182a2303e · 2013 · External reference
